Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge

Huan Ma; Dan Zhao; Weihong Zeng; Yunru Yang; Xiaowen Hu; Peigen Zhou; Jianping Weng; Linzhao Cheng; Xueying Zheng; Tengchuan Jin

doi:10.1007/s11427-020-1805-0

Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge

Sci China Life Sci. 2021 Mar;64(3):482-485. doi: 10.1007/s11427-020-1805-0. Epub 2020 Aug 28.

Authors

Huan Ma^#^{1

2}, Dan Zhao^#², Weihong Zeng^#^{1

2}, Yunru Yang², Xiaowen Hu³, Peigen Zhou⁴, Jianping Weng^{1

5

6}, Linzhao Cheng^{7

8}, Xueying Zheng^{9

10

11}, Tengchuan Jin^{12

13

14}

Affiliations

¹ The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
² Hefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.
³ Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
⁴ Department of Statistics, University of Wisconsin-Madison, Madison, WI, 53706, USA.
⁵ Joint Laboratory of Public Health, University of Science and Technology of China and Health Commission of Anhui Province, Hefei, 230026, China.
⁶ Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, 230001, China.
⁷ Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei Anhui, 230026, China.
⁸ Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
⁹ The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. [email protected].
¹⁰ Joint Laboratory of Public Health, University of Science and Technology of China and Health Commission of Anhui Province, Hefei, 230026, China. [email protected].
¹¹ Clinical Research Hospital (Hefei) of Chinese Academy of Science, Hefei, 230001, China. [email protected].
¹² The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China. [email protected].
¹³ Hefei National Laboratory for Physical Sciences at Microscale, Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. [email protected].
¹⁴ CAS Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. [email protected].

^# Contributed equally.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral / blood
COVID-19 / blood
COVID-19 / immunology*
Female
Hospitalization*
Humans
Immunoglobulin A / blood*
Immunoglobulin G / blood*
Immunoglobulin M / blood*
Male
Patient Discharge*
SARS-CoV-2 / immunology*

Substances

Antibodies, Viral
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M